Holen Sie sich die Stockscreener-App
37.99
0.18%
0.07
Handel nachbörslich:
37.99
Schlusskurs vom Vortag:
$37.92
Offen:
$37.65
24-Stunden-Volumen:
229.88K
Relative Volume:
1.85
Marktkapitalisierung:
$543.23M
Einnahmen:
$138.20M
Nettoeinkommen (Verlust:
$5.52M
KGV:
99.97
EPS:
0.38
Netto-Cashflow:
$9.86M
1W Leistung:
+8.45%
1M Leistung:
+23.06%
6M Leistung:
+11.21%
1J Leistung:
-5.07%
1-Tages-Spanne:
$37.65
$38.31
1-Wochen-Bereich:
$34.76
$38.50
52-Wochen-Spanne:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Firmenname
Surmodics Inc
Sektor
Branche
Telefon
(952) 500-7000
Adresse
9924 W 74TH ST, EDEN PRAIRIE, MN
Vergleichen Sie SRDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
37.99 | 542.17M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Hochstufung | Lake Street | Hold → Buy |
| 2023-06-13 | Hochstufung | Needham | Hold → Buy |
| 2023-02-13 | Herabstufung | Needham | Buy → Hold |
| 2020-07-23 | Hochstufung | Needham | Hold → Buy |
| 2019-12-11 | Herabstufung | Needham | Buy → Hold |
| 2019-11-01 | Herabstufung | Lake Street | Buy → Hold |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Lake Street | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-02-21 | Bestätigt | Needham | Buy |
| 2018-05-16 | Bestätigt | Needham | Buy |
| 2018-03-01 | Hochstufung | Sidoti | Neutral → Buy |
| 2018-02-28 | Bestätigt | Lake Street | Buy |
| 2018-02-28 | Eingeleitet | Needham | Buy |
| 2017-07-14 | Eingeleitet | Lake Street | Buy |
| 2016-11-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-05-03 | Bestätigt | Barrington Research | Outperform |
| 2015-08-06 | Bestätigt | Barrington Research | Outperform |
| 2015-03-27 | Eingeleitet | Dougherty & Company | Buy |
| 2014-02-25 | Eingeleitet | Laidlaw | Buy |
| 2013-08-01 | Hochstufung | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Surmodics Inc Aktie (SRDX) Neueste Nachrichten
FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix - Law360
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts - TradingView
What is the target price for Surmodics Inc. stockPrice Volume Breakout Screener - newsyoung.net
Is Surmodics Inc. exposed to political riskQuality Dividend Stock Finder - newsyoung.net
Surmodics (SRDX) Maintains Market Perform Rating by Barrington Research - AInvest
SurModics Maintains Hold Rating Amid Mixed Financial Performance and Ongoing Litigation - AInvest
Surmodics revenue down 3% to USD 29.6M in Q3 2025 - Medical Buyer
Surmodics 2025 Q3 Earnings Loss Narrows 29.6% - AInvest
SurModics' Strong Financials Offset by Acquisition Uncertainty - AInvest
SurModics: Fiscal Q3 Earnings Snapshot - Connecticut Post
Surmodics Lifts Guidance Despite Dips In Device Revenue - Finimize
GTCR, Surmodics file opposition to US FTC's motion for preliminary injunction - MLex
UPDATE: FTC request for GTCR/Surmodics divestiture docs denied - Global Competition Review
FTC seeks GTCR/Surmodics divestiture docs - Global Competition Review
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
SurModics earnings beat by $0.25, revenue topped estimates - Investing.com Canada
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
SURMODICS INC SEC 10-Q Report - TradingView
Surmodics raises FY25 EPS view to (35c)-(20c) from (62c)-(42c) - TipRanks
SURMODICS Earnings Results: $SRDX Reports Quarterly Earnings - Quiver Quantitative
Medical device maker Surmodics's Q3 revenue dips 3%, FY guidance raised - MarketScreener
Surmodics (SRDX) Q3 EPS Turns Positive - AOL.com
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - The Globe and Mail
Surmodics Reports Third Quarter Fiscal 2025 Financial Results - TradingView
What data driven models say about Surmodics Inc.’s futureDaily Trade Monitor with Pattern Alerts - Newser
Will Surmodics Inc. rebound enough to break evenRSI and MACD Signal Summary with Trends - Newser
Is Surmodics Inc. meeting your algorithmic filter criteriaAsset Growth Pattern and Return Summary - Newser
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - BioSpace
Press Release: Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - 富途牛牛
Is it the right time to buy Surmodics Inc. stockUnmatched profit growth - Jammu Links News
How does Surmodics Inc. generate profit in a changing economyAchieve breakthrough performance in the market - Jammu Links News
Why is Surmodics Inc. stock attracting strong analyst attentionUnlock superior stock analysis tools - Jammu Links News
When is Surmodics Inc. stock expected to show significant growthDiscover the fastest growing stocks today - Jammu Links News
How many analysts rate Surmodics Inc. as a “Buy”Massive stock growth - Jammu Links News
Surmodics Inc. Stock Analysis and ForecastFree Capital Allocation Plans - Jammu Links News
What is the risk reward ratio of investing in Surmodics Inc. stockOutstanding investment returns - Jammu Links News
Analyzing drawdowns of Surmodics Inc. with statistical toolsFree Day Trading Signals With High Precision - Newser
how surmodics inc. stock performs during market volatilityCapital Growth Plan for New Investors - Newser
Is Surmodics Inc. stock a growth or value playFree Step-by-Step Trade Signal Implementation - Newser
Is this a good reentry point in Surmodics Inc.Free Daily Growth Stock Pick Reports - Newser
What institutional investors are buying Surmodics Inc. stockExpert Picks Planner For Beginners - Jammu Links News
Volume Surge May Signal Institutional Interest in Surmodics Inc.Real Trader Watchlist of Hot Stocks Released - metal.it
Is a relief rally coming for Surmodics Inc. holdersReal-Time Trade Insights Spark Market Reactions - metal.it
Surmodics falls as parties, FTC ask for extension of briefing schedule - Seeking Alpha
How Efficient Is Surmodics Inc. at Controlling Operating CostsBuy Strategy Tracker with Growth Indicators - Newser
Is Surmodics Inc. stock a good hedge against inflationControlled Entry Strategy With Safety Analytics - Newser
Finanzdaten der Surmodics Inc-Aktie (SRDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):